Pathogenic variants of TUBB8 cause oocyte spindle defects by disrupting with EB1/CAKP5 interactions and potential treatment targeting microtubule acetylation through HDAC6 inhibition

Hui Luo, Jianhua Chen, Li Cao, Tian Wu, Siyue Yin, Guangping Yang, Yipin Wang, Zhen Guo, Saifei Hu, Yanni He, Yingnan Wang, Yao Chen, You‐Qiang Su, Congxiu Miao, Yun Qian, Ruizhi FengClinical 2025 · DOI

TL;DR

Pathogenic variants in the TUBB8 gene disrupt oocyte spindle formation by interfering with the interaction between EB1 and microtubules, leading to female infertility. This study not only elucidates this mechanism but also demonstrates that inhibiting HDAC6 can rescue these defects, offering a potential therapeutic avenue.

What Problem Does This Paper Address?

Female infertility is a significant global health issue, and a substantial portion of cases are linked to oocyte maturation arrest. While some genetic causes are known, a considerable number of TUBB8 gene variants, particularly missense variants that don't reduce tubulin dimer levels, remain unexplained. These variants impair microtubule dynamics and spindle assembly, leading to infertility. Understanding the precise molecular mechanisms behind these unexplained variants is crucial for developing effective diagnostic and therapeutic strategies.

Methods

The researchers employed a multi-pronged approach:

  • In vitro microinjection: They injected mutated TUBB8 mRNA into mouse oocytes to observe the immediate effects on spindle formation and microtubule dynamics.
  • Oocyte-specific knock-in mouse models: They generated mice with specific TUBB8 mutations (D417N) in their oocytes to study the long-term effects in a more physiologically relevant context.
  • Live-cell imaging and immunofluorescence: These techniques were used to visualize and track microtubule dynamics, spindle assembly, and the localization of key proteins (like EB1, CKAP5, and Ran-GTP) in real-time and in fixed cells.
  • Co-immunoprecipitation and mass spectrometry: These methods were used to identify protein-protein interactions and to analyze the proteomic changes occurring in oocytes with TUBB8 mutations.
  • In vitro translation assays: These were used to investigate whether the TUBB8 variants affected the folding and assembly of tubulin heterodimers.
  • Pharmacological inhibition: They used specific inhibitors (Tubacin, Tubastatin A) to target HDAC6 activity and assess its impact on rescuing the observed defects.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • EB1 is a critical mediator: The study strongly implicates EB1, a microtubule plus-end tracking protein, as a key player whose interaction with microtubules is disrupted by the TUBB8 D417N variant. This disruption is central to the observed spindle defects.
  • CKAP5 and TACC3 localization is affected: The D417N variant leads to aberrant localization of CKAP5 and TACC3, crucial microtubule nucleation factors, which further contributes to spindle assembly failure.
  • Ran-GTP pathway disruption: The D417N variant perturbs the Ran-GTP pathway, which is essential for spindle assembly, by reducing active Ran-GTP and increasing RanGAP1 activity. This leads to improper recruitment of spindle assembly factors like TPX2 and NuMA.
  • Microtubule acetylation is key: The D417N variant causes a significant decrease in microtubule acetylation, a marker of stable microtubules. This is linked to increased activity of HDAC6, a deacetylase.
  • HDAC6 inhibition is a viable therapeutic strategy: Inhibiting HDAC6 with drugs like Tubacin or Tubastatin A effectively rescues spindle morphology, microtubule acetylation, and polar body extrusion rates in TUBB8-mutant oocytes, offering a promising therapeutic avenue.

Key Results

  • Microinjection of mutated TUBB8 mRNA (R262Q, M300I, D417N) led to significant depletion of EB1 signal and impaired polar body extrusion.
  • Oocyte-specific TUBB8-D417N knock-in mice showed metaphase I arrest in ~75% of oocytes, with abnormal spindles and reduced polar body extrusion rates compared to wild-type.
  • The D417N variant did not affect tubulin heterodimer assembly but significantly reduced EB1 binding to microtubules.
  • The D417N variant disrupted the localization of CKAP5 and TACC3, key microtubule nucleation factors.
  • The Ran-GTP pathway was perturbed in D417N oocytes, leading to reduced active Ran-GTP and impaired recruitment of TPX2 and NuMA.
  • Microtubule acetylation was significantly reduced in D417N oocytes, accompanied by increased HDAC6 expression.
  • Treatment with HDAC6 inhibitors (Tubacin, Tubastatin A) rescued spindle morphology, microtubule acetylation, and polar body extrusion rates in D417N oocytes, as well as other TUBB8 variants like I210V and M363T.

Limitations and Future Work

  • In vitro vs. in vivo: While microinjection provides rapid insights, the knock-in mouse model offers a more comprehensive view of the in vivo effects.
  • Complexity of tubulin regulation: The paper acknowledges the intricate nature of tubulin post-translational modifications and their role in oocyte maturation, suggesting further investigation into these pathways.
  • Therapeutic translation: While HDAC6 inhibitors showed promising rescue effects in oocytes, further research is needed to assess their safety and efficacy for direct clinical application in patients. The authors suggest that repurposing clinically applicable HDAC6 inhibitors might be a future direction.
  • Broader applicability of HDAC6 inhibition: The study demonstrated rescue for D417N, I210V, and M363T variants, suggesting that HDAC6 inhibition might be a general therapeutic strategy for a subset of TUBB8-related infertility. Further studies could explore this more broadly.

Summary updated

Abstract

Our study provides a comprehensive mechanism elucidating how TUBB8 missense variants cause oocyte maturation arrest and offers new therapeutic avenues for treating female infertility in the clinic.
BibTeX
@inproceedings{luo2025pathogenic,
  author = {Hui Luo and Jianhua Chen and Li Cao and Tian Wu and Siyue Yin and Guangping Yang and Yipin Wang and Zhen Guo and Saifei Hu and Yanni He and Yingnan Wang and Yao Chen and You‐Qiang Su and Congxiu Miao and Yun Qian and Ruizhi Feng},
  title = {{Pathogenic variants of TUBB8 cause oocyte spindle defects by disrupting with EB1/CAKP5 interactions and potential treatment targeting microtubule acetylation through HDAC6 inhibition}},
  booktitle = {Clinical},
  year = {2025},
  doi = {10.1002/ctm2.70193},
}
Figure